Profile data is unavailable for this security.
About the company
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
- Revenue in USD (TTM)560.03m
- Net income in USD-150.66m
- Incorporated2006
- Employees2.00k
- LocationiRhythm Technologies Inc699 8th Street, Suite 600SAN FRANCISCO 94103United StatesUSA
- Phone+1 (415) 632-5700
- Fax+1 (302) 655-5049
- Websitehttps://www.irhythmtech.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Integra Lifesciences Holdings Corp | 1.56bn | -6.54m | 1.77bn | 3.95k | -- | 1.17 | 13.89 | 1.13 | -0.0881 | -0.0881 | 20.22 | 19.73 | 0.401 | 1.59 | 5.99 | 396,583.90 | -0.1677 | 3.33 | -0.2002 | 3.68 | 59.29 | 63.67 | -0.4182 | 7.99 | 0.7261 | 4.05 | 0.5428 | 0.00 | -1.03 | 0.9219 | -62.48 | 2.19 | -2.97 | -- |
Patterson Companies, Inc. | 6.53bn | 168.41m | 1.79bn | 7.60k | 11.08 | 1.88 | 6.93 | 0.2736 | 1.83 | 1.83 | 71.22 | 10.80 | 2.27 | 5.86 | 15.35 | 859,640.70 | 5.84 | 1.13 | 10.15 | 1.81 | 21.03 | 20.98 | 2.57 | 0.5157 | 0.6723 | 7.91 | 0.4474 | 304.75 | 1.50 | 3.34 | -10.42 | 18.10 | 2.17 | 0.00 |
Rxsight Inc | 128.29m | -30.69m | 1.82bn | 374.00 | -- | 6.54 | -- | 14.15 | -0.8194 | -0.8194 | 3.40 | 6.89 | 0.5212 | 1.99 | 6.32 | 343,029.40 | -12.47 | -- | -13.62 | -- | 68.44 | -- | -23.92 | -- | 11.71 | -- | 0.0005 | -- | 81.77 | -- | 27.19 | -- | -- | -- |
Novocure Ltd | 577.74m | -149.78m | 1.85bn | 1.45k | -- | 5.12 | -- | 3.20 | -1.39 | -1.39 | 5.37 | 3.34 | 0.4879 | 3.59 | 8.74 | 397,617.30 | -12.65 | -7.74 | -20.29 | -8.95 | 76.42 | 77.22 | -25.93 | -14.69 | 1.44 | -- | 0.6446 | -- | -5.30 | 15.47 | -123.75 | -- | 32.19 | -- |
Tandem Diabetes Care Inc | 854.35m | -126.78m | 2.02bn | 2.40k | -- | 8.49 | -- | 2.36 | -1.94 | -1.94 | 13.08 | 3.62 | 0.9004 | 2.90 | 8.23 | 355,979.60 | -13.36 | -10.08 | -17.47 | -12.23 | 49.79 | 51.77 | -14.84 | -11.59 | 2.32 | -- | 0.5945 | -- | -6.68 | 32.39 | -135.33 | -- | 76.81 | -- |
Omnicell Inc | 1.06bn | -17.69m | 2.03bn | 3.66k | -- | 1.66 | 30.57 | 1.91 | -0.3917 | -0.3917 | 23.17 | 26.59 | 0.4704 | 5.90 | 4.06 | 291,563.30 | -0.7817 | 1.73 | -1.11 | 2.25 | 41.44 | 46.69 | -1.66 | 2.92 | 0.9529 | -- | 0.3172 | 0.00 | -11.48 | 7.82 | -460.68 | -- | 0.235 | -- |
Premier Inc | 1.28bn | 147.17m | 2.15bn | 2.90k | 16.23 | 1.12 | 8.21 | 1.69 | 1.38 | 1.37 | 11.65 | 19.98 | 0.3562 | -- | 2.99 | 439,914.10 | 3.83 | 7.08 | 4.78 | 8.95 | 67.24 | 61.29 | 10.76 | 16.05 | -- | -- | 0.2771 | 27.32 | 0.7684 | 2.03 | -31.70 | -11.93 | -2.76 | -- |
Conmed Corp | 1.29bn | 131.74m | 2.22bn | 4.00k | 16.96 | 2.37 | 10.88 | 1.72 | 4.23 | 4.23 | 41.38 | 30.21 | 0.555 | 1.71 | 5.58 | 322,029.00 | 5.68 | 0.8972 | 6.62 | 1.02 | 55.65 | 54.95 | 10.23 | 1.65 | 1.06 | 5.22 | 0.5021 | 139.16 | 19.06 | 7.68 | 179.99 | 10.04 | 2.89 | 0.00 |
Irhythm Technologies Inc | 560.03m | -150.66m | 2.31bn | 2.00k | -- | 32.22 | -- | 4.13 | -4.85 | -4.85 | 18.04 | 2.29 | 0.83 | 12.56 | 8.79 | 280,012.50 | -22.33 | -21.92 | -26.27 | -26.77 | 67.83 | 69.39 | -26.90 | -25.75 | 6.12 | -24.18 | 0.90 | -- | 19.90 | 27.32 | -6.24 | -- | 50.82 | -- |
UFP Technologies Inc | 461.85m | 54.21m | 2.34bn | 3.09k | 43.55 | 7.11 | 34.79 | 5.06 | 7.00 | 7.00 | 59.64 | 42.89 | 0.8896 | 4.18 | 6.15 | 149,320.40 | 10.44 | 9.69 | 12.00 | 10.95 | 28.31 | 26.33 | 11.74 | 10.14 | 1.43 | 13.44 | 0.3919 | 0.00 | 13.08 | 16.00 | 7.50 | 25.71 | 14.08 | -- |
LeMaitre Vascular Inc | 213.03m | 41.32m | 2.38bn | 614.00 | 58.07 | 7.19 | 46.72 | 11.17 | 1.82 | 1.82 | 9.41 | 14.73 | 0.5992 | 1.11 | 7.59 | 346,952.80 | 11.62 | 9.02 | 12.66 | 9.93 | 68.34 | 65.83 | 19.40 | 15.45 | 5.52 | -- | 0.00 | 40.41 | 19.69 | 12.88 | 45.89 | 5.96 | 18.93 | 15.51 |
Quidelortho Corp | 2.82bn | -1.87bn | 2.55bn | 7.10k | -- | 0.799 | -- | 0.9044 | -27.89 | -27.89 | 42.04 | 47.42 | 0.3674 | 2.62 | 7.84 | 396,859.20 | -24.34 | 11.34 | -27.75 | 12.91 | 47.62 | 62.71 | -66.25 | 20.93 | 0.8134 | 0.7419 | 0.4446 | 0.00 | -8.21 | 41.83 | -101.84 | -- | 45.87 | -- |
Enovis Corp | 2.00bn | -121.38m | 2.58bn | 6.55k | -- | 0.7745 | 17.63 | 1.29 | -2.21 | -2.17 | 36.43 | 59.61 | 0.4023 | 1.59 | 5.91 | 305,598.20 | -2.43 | -0.3569 | -2.66 | -0.41 | 56.96 | 48.19 | -6.03 | -1.06 | 1.12 | 0.9889 | 0.2876 | -- | 9.22 | -4.89 | -40.29 | -- | 11.91 | -- |
TransMedics Group Inc | 401.09m | 32.64m | 2.66bn | 584.00 | 84.50 | 12.68 | 52.79 | 6.64 | 0.9389 | 0.9389 | 11.60 | 6.25 | 0.5439 | 3.56 | 5.32 | 686,797.90 | 4.43 | -16.08 | 4.78 | -17.95 | 59.34 | 65.37 | 8.14 | -40.47 | 7.33 | -- | 0.7078 | -- | 158.53 | 79.36 | 30.92 | -- | 225.12 | -- |
Warby Parker Inc | 742.53m | -32.56m | 2.80bn | 2.14k | -- | 8.31 | 246.87 | 3.77 | -0.2731 | -0.2731 | 6.20 | 2.80 | 1.22 | 5.70 | 818.21 | 346,975.20 | -5.37 | -- | -6.78 | -- | 55.32 | 57.49 | -4.39 | -14.53 | 2.06 | -- | 0.00 | -- | 11.98 | 19.67 | 42.75 | -- | -- | -- |
LivaNova PLC | 1.24bn | 23.68m | 2.81bn | 2.90k | 121.38 | 2.14 | 41.37 | 2.26 | 0.4259 | 0.4259 | 22.81 | 24.13 | 0.5119 | 2.47 | 6.42 | 428,185.90 | 0.9777 | -6.01 | 1.12 | -7.42 | 67.78 | 66.99 | 1.91 | -13.56 | 2.87 | 2.46 | 0.3234 | -- | 12.89 | 0.8278 | 120.34 | -- | -1.64 | -- |
Holder | Shares | % Held |
---|---|---|
Sands Capital Management LLCas of 31 Oct 2024 | 3.14m | 10.06% |
The Vanguard Group, Inc.as of 30 Sep 2024 | 3.03m | 9.69% |
Artisan Partners LPas of 30 Sep 2024 | 2.78m | 8.90% |
BlackRock Fund Advisorsas of 30 Sep 2024 | 2.29m | 7.32% |
Capital Research & Management Co. (Global Investors)as of 30 Sep 2024 | 1.96m | 6.26% |
Mackenzie Financial Corp.as of 30 Sep 2024 | 1.42m | 4.55% |
AllianceBernstein LPas of 30 Sep 2024 | 1.21m | 3.88% |
SSgA Funds Management, Inc.as of 30 Sep 2024 | 908.84k | 2.91% |
Braidwell LPas of 30 Sep 2024 | 782.56k | 2.51% |
Eventide Asset Management LLCas of 30 Sep 2024 | 736.72k | 2.36% |